SCHEMBL2235

SCHEMBL2235

CN(C)/C=C/C(=O)c1c[nH]c2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
MAOB P27338 1/20 0.57
PBRM1 Q86U86 1/20 0.57
GPR84 Q9NQS5 1/20 0.56
ALDH1A1 P00352 3/20 0.53
ATM Q13315 1/20 0.53
NR4A2 P43354 1/20 0.53
CREBBP Q92793 1/20 0.53
CTNNB1 P35222 3/20 0.50
WNT3A P56704 3/20 0.50
LMNA P02545 2/20 0.50
KMT2A Q03164 2/20 0.50
ADAM17 P78536 1/20 0.50
RECQL P46063 1/20 0.50
MAPK1 P28482 2/20 0.49
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2236 1.00 NPC1 (0.62) NPC1RAB9ATDP1MAOBPBRM1
SCHEMBL2229945 0.80 HTT (0.50) NPC1RAB9ATDP1MAOBLMNA
SCHEMBL2229950 0.80 HTT (0.50) NPC1RAB9ATDP1MAOBLMNA
SCHEMBL6495175 0.80 NPC1 (0.72) NPC1RAB9ATDP1MAOBPBRM1
SCHEMBL6495182 0.80 NPC1 (0.72) NPC1RAB9ATDP1MAOBPBRM1
SCHEMBL13991177 0.77 MAP2K1 (0.58) LMNAKMT2ARECQLMAPTPIM1
SCHEMBL13357712 0.77 MAP2K1 (0.58) LMNAKMT2ARECQLMAPTPIM1
SCHEMBL2728702 0.77 GPR84 (0.67) NPC1RAB9ATDP1MAOBPBRM1
SCHEMBL657691 0.77 NPC1 (1.00) NPC1RAB9ATDP1MAOBPBRM1
SCHEMBL29522745 0.77 NPC1 (1.00) NPC1RAB9ATDP1MAOBPBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0233461-B2 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 2002-05-29 EP disclosed
US-5521184-A ANTITUMOR AGENTS; imatinib mesylate CIBA-GEIGY CORPORATION (US) 1996-05-28 US disclosed
EP-0233461-B1 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 1996-03-20 EP disclosed
EP-0672040-A1 FURTHER PYRIMIDINE DERIVATIVES AND THEIR PREPARATION Novartis AG (CH) 1995-09-20 EP disclosed
WO-1995009852-A1 FURTHER PYRIMIDINE DERIVATIVES AND THEIR PREPARATION CIBA-GEIGY AG (CH) 1995-04-13 WO disclosed
US-4876252-A ADMINISTERING ANTIASTHMATIC OR ANTIALLERGEN AMERICAN CYANAMID COMPANY (US) 1989-10-24 US disclosed
US-4788195-A TREATING ASTHMA, ALLERGIC DISEASES, INFLAMMATION AND DIABETES IN MAMMALS AMERICAN CYANAMID COMPANY (US) 1988-11-29 US disclosed
EP-0233461-A2 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID COMPANY (US) 1987-08-26 EP disclosed